Advertisement
Screener

DAMORA THERAPEUTICS, INC. (DMRA) ROE

DAMORA THERAPEUTICS, INC. (DMRA) ROE

  • 2026-06-30: ROE -50.93%.
  • 2026-03-31: ROE -45.95%.
  • 2025-12-31: ROE -87.29%.
  • 2025-09-30: ROE -197.88%.

Complete source-backed roe history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-50.93%
2026-03-31-45.95%
2025-12-31-87.29%
2025-09-30-197.88%
2025-06-30-151.50%
2025-03-31-134.91%
2024-12-31-135.42%
2024-09-30-101.14%
2024-06-30-107.79%
2024-03-31-109.49%
2023-12-31-118.61%
2023-09-30-122.90%
2023-06-30-117.93%
2023-03-31-114.60%
2022-12-31-99.79%
2022-09-30-83.83%
2022-06-30-70.45%
2022-03-31-54.63%
2021-12-31-44.15%
2021-09-30-38.51%
2021-06-30-34.56%
2021-03-31-27.86%
2020-12-31-21.05%
2020-09-3051.98%
2020-06-3048.62%

Annual ROE

DateROE
2025-12-31-87.29%
2024-12-31-135.42%
2023-12-31-118.61%
2022-12-31-99.79%
2021-12-31-44.15%
2020-12-31-21.05%
2019-12-3151.31%

Similar stocks

Stock NameCountryMarket CapPE Ratio
HARROW, INC. (HROW)United States$1.240B-42.77
Avalyn Pharma Inc. (AVLN)United States$1.267B
OPKO HEALTH, INC. (OPK)United States$1.220B-15.59
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Jaguar Health, Inc. (JAGX)United States$1.184B
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Kardigan, Inc. (KARD)United States$1.346B